Evaluates inpatient and emergency room visits following cenobamate initiation compared to other medications, suggesting its influence on healthcare demands.
To evaluate the comparative effect of initiating cenobamate vs selected antiseizure medications (ASMs, brivaracetam, clobazam, eslicarbazepine, lacosamide, or perampanel) on epilepsy-related and all-cause inpatient (IP) and emergency room (ER) utilization rates.
No takes yet. Share an insight, caveat, or question.
Klatte et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: